Abstract:ID 87806 Poster Board 496 Benzodiazepines (BZs) are safe and effective therapeutics for anxiety when used as directed, however, BZs have unwanted side effects like potential for misuse, physical dependence, and toxicity when combined with other substances. BZs bind to a site on the GABA A receptor located at the interface of the alpha and gamma subunit, with alpha 1, alpha 2, and alpha 3 subunit-containing receptors likely involved in their reinforcing effects. Furthermore, compounds that lack efficacy at the alpha 1 subunit-containing GABA A receptor (alpha 1 sparing compounds) appear to have reduced addiction potential, though their reinforcing effects are dependent upon past drug experience. Choice procedures were used to evaluate whether subjects without prior drug experience would self-administer alpha 1 sparing compounds when substituted for food or when combined with food. Two female and two male rhesus monkeys chose between a fixed food amount on one option (1 or 2 pellets/delivery) and on the other option, in different conditions, between increasing food amounts (0-4 pellets/delivery), increasing drug doses (0-0.1 mg/kg/injection), or increasing food amounts combined with a fixed drug dose (0-0.1 mg/kg/injection). Three alpha 1 sparing compounds with various levels of functional selectivity at alpha 2, alpha 3, and alpha 5 subunit-containing GABA A receptors (a2GABA A , a3GABA A , a5GABA A , respectively) were evaluated. The compounds YT-III-31 (0-0.1 mg/kg/injection), MP-III-24 (0-0.1 mg/kg/injection), and MP-III-80 (0-0.1 mg/kg/injection), with functional selectivity for a3GABA A , a2/3GABA A , and a2/3/5GABA A receptors, respectively, were not self-administered on their own, and failed to reliably produce enhancement of food choice. These results suggest that alpha 1 sparing compounds do not function as reinforcers on their own in drug naïve subjects and is similar to outcomes obtained with cocaine-experienced subjects. However, unlike with cocaine experience, alpha 1 sparing compounds did not reliably enhance choice of another reinforcer (i.e., food). These experiments are currently being replicated with a nonselective BZ, midazolam, and the alpha 1 preferring compound, zolpidem, in the same subjects. From a therapeutic perspective, alpha 1 sparing compounds may hold promise as treatments for anxiety with reduced potential for misuse and in the treatment of BZ use disorder. This research is supported by the National Institute on Drug Abuse (NIDA) grants DA054177 and DA045011 to S.L.H, DA011792 to J.K.R., DA039167 to K.B.F., and subawards to J.M.C under NIDA grants R01DA043204 and R01DA054177 and National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant R01AA029023.

Self-Administration of Benzodiazepines in Drug-Naïve Rhesus Monkeys: Role of GABAA Receptor Subtypes

Evaluation of the sedative-motor effects of novel GABAkine imidazodiazepines using quantitative observation techniques in rhesus monkeys

Self-administration of progesterone and synthetic neuroactive steroids by male rhesus monkeys

Self-Administration of Fentanyl-Alprazolam Combinations by Rhesus Monkeys Responding under a Progressive-Ratio Schedule

Behavioral effects of triazolam and pregnanolone combinations: reinforcing and sedative-motor effects in female rhesus monkeys

Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys

Nonsedating anxiolytics

The Effects of Orexin Antagonists on Economic Choice between Remifentanil and Milk in Squirrel Monkeys

Anxious behavior and fenfluramine-induced prolactin secretion in young rhesus macaques with different alleles of the serotonin reuptake transporter polymorphism (5HTTLPR)

Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys

New Insights Into Pharmacology of GABAA Receptor Alpha Subunits-Selective Modulators

'I haven't discussed anything with anyone': lived experience of long-term users of benzodiazepine receptor agonists regarding their treatment for substance use disorder

Setting the Record Straight on Long-Term Use, Dose Escalation, and Potential Misuse of Prescription Benzodiazepines

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability

Evaluation of potential punishing effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rhesus monkeys responding under a choice procedure

Cannabinoid Antagonist Drug Discrimination In Nonhuman Primates

Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes

The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam

Negative Allosteric Modulation of Gamma-Aminobutyric Acid A Receptors at α5 Subunit–Containing Benzodiazepine Sites Reverses Stress-Induced Anhedonia and Weakened Synaptic Function in Mice

Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial

A comparison of plasma alprazolam concentrations following different routes of chronic administration in the Sprague-Dawley rat: implications for psychotropic drug research